Citation Impact
Citing Papers
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
2010
Isothermal amplified detection of DNA and RNA
2014
CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing
2017 StandoutNobel
Bile acid transporters
2009
Head and neck squamous cell carcinoma
2020 Standout
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
2013 Standout
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse
2005
Apolipoprotein E-Containing Lipoproteins Protect Neurons from Apoptosis via a Signaling Pathway Involving Low-Density Lipoprotein Receptor-Related Protein-1
2007
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Gut microbiota functions: metabolism of nutrients and other food components
2017 Standout
Immunological biomarkers of tuberculosis
2011
Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins
2004
Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease
2010
The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes
2005
Nanotechnology as a therapeutic tool to combat microbial resistance
2013 Standout
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
2009
Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects
2009 Standout
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
2015 StandoutNobel
Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review
2012
LincSNP 2.0: an updated database for linking disease-associated SNPs to human long non-coding RNAs and their TFBSs
2016
Bile Acid Signaling in Metabolic Disease and Drug Therapy
2014
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
FXR signaling in the enterohepatic system
2012
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
The role of scavenger receptor class B type I (SR-BI) in lipid trafficking
2003
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis
2007 Standout
The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis
2016
Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats
2014
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Transactivation of Rat Apical Sodium-Dependent Bile Acid Transporter and Increased Bile Acid Transport by 1α,25-Dihydroxyvitamin D3 via the Vitamin D Receptor
2006
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Coordinate Transcriptional Regulation of Transport and Metabolism
2005
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Effects of sodium butyrate in animal models of mania and depression
2013
Hepatitis C Virus Entry
2007 StandoutNobel
The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships
2006
Hydrogen peroxide – production, fate and role in redox signaling of tumor cells
2015
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Animal models of obesity and diabetes mellitus
2018
Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling
2012
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
2015
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
2021 StandoutNobel
Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation
2011
Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain
2015
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
2016 StandoutNatureNobel
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Discovery of Rolling Circle Amplification and Rolling Circle Transcription
2016 Standout
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
2003
Deciphering the nuclear bile acid receptor FXR paradigm
2010
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
2016
Isothermal Amplification and Molecular Typing of the Obligate Intracellular Pathogen Mycobacterium leprae Isolated from Tissues of Unknown Origins
2006
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations
2006
A novel hybrid decision making approach for the strategic selection of wind energy projects
2021 Standout
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Diagnosing COVID-19: The Disease and Tools for Detection
2020 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
2021
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
2005
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms
2010
Do subsidies improve the financial performance of renewable energy companies? Evidence from China
2018
Combination therapy for the treatment of pancreatic cancer through hyaluronic acid‐decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro study
2018
The Immune Response in Tuberculosis
2013 Standout
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Hypervariable Region 1 Deletion and Required Adaptive Envelope Mutations Confer Decreased Dependency on Scavenger Receptor Class B Type I and Low-Density Lipoprotein Receptor for Hepatitis C Virus
2013
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Inhibition of Cholesteryl Ester Transfer Protein Activity by JTT-705 Increases Apolipoprotein E–Containing High-Density Lipoprotein and Favorably Affects the Function and Enzyme Composition of High-Density Lipoprotein in Rabbits
2004
Green fluorescent protein‐tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress
2016 StandoutNobel
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
The Role of FXR in Disorders of Bile Acid Homeostasis
2008
Works of Xiaoping Li being referenced
Mechanism of Excess Capacity Based on China's Regional Competition and Market Distortion
2012
Detection of rare DNA targets by isothermal ramification amplification
2001
Reconstituted Discoidal ApoE-Phospholipid Particles Are Ligands for the Scavenger Receptor BI
2002
Association between the CYP1A1 A2455G polymorphism and risk of cancer: evidence from 272 case–control studies
2013
Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications
2015
Intracerebroventricular administration of ouabain as a model of mania in rats
2003
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter
2004
Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII
2011
Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry
2009
Expression and significance of CD44 and p-AKT in pancreatic head cancer
2015
Molecular Mechanisms of Type III Hyperlipoproteinemia: The Contribution of the Carboxy-Terminal Domain of ApoE Can Account for the Dyslipidemia That Is Associated with the E2/E2 Phenotype
2003
Strong evidence for LncRNA ZNRD1-AS1, and its functional Cis- eQTL locus contributing more to the susceptibility of lung cancer
2016